2-year outcomes of phased radiofrequency ablation for atrial fibrillation with the second-generation PVAC Gold ablation catheter

摘要

Abstract Purpose The second-generation multi-electrode catheter, PVAC Gold, was designed to improve the safe delivery of phased radiofrequency energy using a “single shot” approach for pulmonary vein isolation (PVI), while retaining efficacy. This large registry presents long-term performance in a daily practice setting.Methods A total of 1011 patients undergoing first time ablation for atrial fibrillation (AF) using PVAC Gold were included, 639 patients with PVI for paroxysmal AF (PAF PVI) and 372 patients with persistent or long-standing persistent AF, divided into 175 patients receiving PVI only (PersAF PVI) and 197 patients receiving PVI with additional substrate ablation (PersAF PVI?+).Results At 24-month follow-up, single procedure freedom from atrial tachyarrhythmia (ATA) was 58 (368/639) in the PAF PVI group, 44 (77/175) in the PersAF PVI group, and 29 (57/197) in the PersAF PVI?+?group. Allowing one repeat procedure in 33 of patients, 76, 65, and 54 were free from ATA at 24?months, respectively. Pulmonary vein reconnection was observed in 98 of patients with recurrent arrhythmia after PVI.Conclusions Although phased RF ablation with PVAC Gold is quick and safe, the efficacy outcomes are modest compared to current mainstream ablation strategies.